"Antimanic Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Agents that are used to treat bipolar disorders or mania associated with other affective disorders.
| Descriptor ID |
D018692
|
| MeSH Number(s) |
D27.505.696.277.950.025 D27.505.954.427.210.950.025 D27.505.954.427.700.872.025
|
| Concept/Terms |
Antimanic Agents- Antimanic Agents
- Agents, Antimanic
- Antimanic Drugs
- Drugs, Antimanic
- Antimanics
Antimanic Effect- Antimanic Effect
- Effect, Antimanic
- Antimanic Effects
- Effects, Antimanic
|
Below are MeSH descriptors whose meaning is more general than "Antimanic Agents".
Below are MeSH descriptors whose meaning is more specific than "Antimanic Agents".
This graph shows the total number of publications written about "Antimanic Agents" by people in this website by year, and whether "Antimanic Agents" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2001 | 1 | 0 | 1 |
| 2003 | 0 | 1 | 1 |
| 2004 | 0 | 1 | 1 |
| 2006 | 0 | 1 | 1 |
| 2007 | 1 | 0 | 1 |
| 2008 | 0 | 1 | 1 |
| 2010 | 1 | 0 | 1 |
| 2012 | 0 | 1 | 1 |
| 2018 | 1 | 0 | 1 |
| 2023 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Antimanic Agents" by people in Profiles.
-
Neural progenitor cells derived from lithium responsive and non-responsive bipolar disorder patients exhibit distinct sensitivity to cell death following methamphetamine. Neuropharmacology. 2023 03 15; 226:109410.
-
Chronotype and cellular circadian rhythms predict the clinical response to lithium maintenance treatment in patients with bipolar disorder. Neuropsychopharmacology. 2019 02; 44(3):620-628.
-
Collaborative role of the pediatrician in the diagnosis and management of bipolar disorder in adolescents. Pediatrics. 2012 Dec; 130(6):e1725-42.
-
Trends in use of second-generation antipsychotics for treatment of bipolar disorder in the United States, 1998-2009. Psychiatr Serv. 2012 Jan; 63(1):83-6.
-
Lamotrigine: an unusual etiology for aseptic meningitis. Neurologist. 2010 Jan; 16(1):35-6.
-
Prevalence and correlates of eating disorder co-morbidity in patients with bipolar disorder. Psychiatry Res. 2008 Oct 30; 161(1):51-8.
-
Lamotrigine treatment of pathologic skin picking: an open-label study. J Clin Psychiatry. 2007 Sep; 68(9):1384-91.
-
Lamotrigine and its applications in the treatment of epilepsy and other neurological and psychiatric disorders. Expert Rev Neurother. 2006 Nov; 6(11):1609-27.
-
An open trial of adjunctive donepezil in attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol. 2005 Dec; 15(6):947-55.
-
Pharmacotherapy outcome in older pathological gamblers: a preliminary investigation. J Geriatr Psychiatry Neurol. 2004 Mar; 17(1):9-12.